Bulletin
Investor Alert

Aug. 7, 2020, 12:12 p.m. EDT

Meningococcal Vaccines Market Research Report 2020 Analysis by Projections, Estimations, Business Competitors, Consumption, Business Model, Future Prospects and Forecast 2025

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Aug 07, 2020 (Heraldkeepers) -- Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits from individual to individual through respiratory beads. It can bring about serious cerebrum harm and is deadly in half of the cases if not treated at the right time; and can leave diligent neurological deformities in upwards of 10-15% of survivors.

The Global Meningococcal Vaccines Market is expected to exceed more than US$ 5.5 billion by 2024 and will grow at a CAGR of more than 12% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, JN-International Medical Corporation, Novartis International AG, GlaxoSmithKline plc, Sanofi S.A. Inc., Serum Institute of India Ltd., Nuron Biotech. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Meningococcal Vaccines Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The scope of the report includes a detailed study of global and regional markets on Global Meningococcal Vaccines Market with the reasons given for variations in the growth of the industry in certain regions.

The Global Meningococcal Vaccines Market has been segmented as below:

The Global Meningococcal Vaccines Market is Segmented on the lines of Type Analysis and Regional Analysis. By Type Analysis this market is segmented on the basis of Polysaccharide Vaccines, by Brand its covers Menomune, Mencevax, NmVac4, Others, Quadri Meningo & Bi Meningo. Conjugate Vaccines, by Brand its covers Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac & NmVac4-DT. Combination Vaccines, by Brand its covers MenHibrix & Menitorix. Men B Vaccines, by Brand its covers Bexsero & Trumenba.

By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Meningococcal Vaccines Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Meningococcal Vaccines Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Meningococcal Vaccines Market are as follows:

? Reshaping global health and development by developing countries.
? NGO's (Non-Profit Organizations) playing an important role in Educating and making awareness through various activities conducted.
? Travel vaccines for meningococcal disease.
? Convenient public-private partnerships to support development of vaccines at low cost.

The restraining factors of Global Meningococcal Vaccines Market are as follows:

? Divergentage groups and prescribed regimen for routine immunization, and unstable and dynamic epidemiology of meningococcal disease.
? To Support the cold chains to deliver vaccines this leads to high cost of vaccination.

Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report

Table of Contents

1 INTRODUCTION

1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 Research Methodology

3 Global Meningococcal Vaccines Market Overview

4 Global Meningococcal Vaccines Market, by Type

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.